The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced ...

Neoadjuvant PD-1 blockade in dMMR tumors "could potentially eradicate the need for chemotherapy, radiation, and surgery in ...

A new topical gel called LUT014 successfully reduced the severity of a painful acne‐like rash that commonly occurs as a side effect of targeted therapy with epidermal growth factor receptor (EGFR) ...

Trial Platform (PTP), led by Drs. Adam Boxer (University of California, San Francisco [UCSF]), Irene Litvan (University of California, San Diego), Julio Rojas (UCSF) and ...

George Warren, PhD, Lead Author and Principal Scientist at Artelo, said, "We are excited to share the results on this novel ...

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during ...

Since 1971, the US has led the world in funding cancer research and developing new treatments that have driven down death ...

Artelo Biosciences advances ART26.12 for psoriasis and CIPN, while ART27.13 shows early promise in cancer-related anorexia ...

Impulse Dynamics® plc, a global medical device company dedicated to improving the lives of people with heart failure (HF), is proud to ...

"The excellent survival responses reported in patients with different tumor types in the Phase 2 study is very exciting, and ...

The nasal vaccine, tested on animals since 2021, may offer a new tool in fighting COVID-19 with a non-invasive, ...

Numerous studies conducted by researchers at Dana-Farber Cancer Institute report progress for cancers including head and neck cancer, metastatic breast cancer and lung cancer.